Metformin is an active substance with antidiabetic and blood sugar-lowering properties for the treatment of type 2 diabetes and obesity. It can be used in combination with Vildagliptin and is administered orally in the form of film-coated tablets.
Comprehensive documentation for drug registration of Metformin can be provided by Biesterfeld as referred.
|CAS-No. || Regulatory || Monograph |
|657-24-9 || CEP, ASMF || BP, EP, USP|